A NOVEL GENE 
DELIVERY
TECHNOLOGY

Symvivo is a clinical stage biotech company that has developed a live cell probiotic-based gene delivery platform. We have programs in the clinical and pre-clinical space in oncology, ischemic heart disease, vaccines and rare-diseases.

Executive Team